602 THE CANDIDATE HCV E1E2MF59 VACCINE IS SAFE IN CHRONIC HEPATITIS C PATIENTS AND ACCELLERATES THE SECOND PHASE VIRAL DECLINE UPON PRIMARY RESPONSE TO PEG-INTERFERON-2A/RIBAVIRIN THERAPYP. Colombatto, Ferruccio Bonino, Antonio Craxı̀ et al.|Journal of Hepatology|2009Cited by 1
Hepatocellular carcinoma (HCC) in cirrhosis type B: risk factors in 366 western european patientsGiovanna Fattovich, G. Realdi, G. Giustina et al.|Unknown|1993Cited by 0